SK15522002A3 - Derivát esteru kyseliny karbaminovej ako inhibítor faktora Xa, spôsob jeho prípravy, jeho použitia a farmaceutický prostriedok, ktorý ho obsahuje - Google Patents
Derivát esteru kyseliny karbaminovej ako inhibítor faktora Xa, spôsob jeho prípravy, jeho použitia a farmaceutický prostriedok, ktorý ho obsahuje Download PDFInfo
- Publication number
- SK15522002A3 SK15522002A3 SK1552-2002A SK15522002A SK15522002A3 SK 15522002 A3 SK15522002 A3 SK 15522002A3 SK 15522002 A SK15522002 A SK 15522002A SK 15522002 A3 SK15522002 A3 SK 15522002A3
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- monosubstituted
- cooa
- coo
- cooar
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Hydrogenated Pyridines (AREA)
- Confectionery (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10027024A DE10027024A1 (de) | 2000-05-31 | 2000-05-31 | Carbaminsäureester |
PCT/EP2001/004112 WO2001092214A1 (de) | 2000-05-31 | 2001-04-10 | Carbaminsäureester als inhibitoren des faktors xa |
Publications (1)
Publication Number | Publication Date |
---|---|
SK15522002A3 true SK15522002A3 (sk) | 2003-03-04 |
Family
ID=7644254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1552-2002A SK15522002A3 (sk) | 2000-05-31 | 2001-04-10 | Derivát esteru kyseliny karbaminovej ako inhibítor faktora Xa, spôsob jeho prípravy, jeho použitia a farmaceutický prostriedok, ktorý ho obsahuje |
Country Status (17)
Country | Link |
---|---|
US (1) | US20030199698A1 (de) |
EP (1) | EP1289941A1 (de) |
JP (1) | JP2003535074A (de) |
KR (1) | KR20030007752A (de) |
AR (1) | AR029931A1 (de) |
AU (1) | AU2001260193A1 (de) |
BR (1) | BR0111059A (de) |
CA (1) | CA2410628A1 (de) |
CZ (1) | CZ20023588A3 (de) |
DE (1) | DE10027024A1 (de) |
HU (1) | HUP0301957A2 (de) |
MX (1) | MXPA02011801A (de) |
NO (1) | NO20025740D0 (de) |
PL (1) | PL358688A1 (de) |
SK (1) | SK15522002A3 (de) |
WO (1) | WO2001092214A1 (de) |
ZA (1) | ZA200210301B (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200410921A (en) * | 2002-11-25 | 2004-07-01 | Hoffmann La Roche | Mandelic acid derivatives |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19530996A1 (de) * | 1995-08-23 | 1997-02-27 | Boehringer Mannheim Gmbh | Cyclische Guanidine, Verfahren zu ihrer Herstellung und Arzneimittel |
DE19755268A1 (de) * | 1997-12-12 | 1999-06-17 | Merck Patent Gmbh | Benzamidinderivate |
DE19819548A1 (de) * | 1998-04-30 | 1999-11-04 | Merck Patent Gmbh | Biphenylderivate |
-
2000
- 2000-05-31 DE DE10027024A patent/DE10027024A1/de active Pending
-
2001
- 2001-04-10 CZ CZ20023588A patent/CZ20023588A3/cs unknown
- 2001-04-10 KR KR1020027016190A patent/KR20030007752A/ko not_active Application Discontinuation
- 2001-04-10 PL PL01358688A patent/PL358688A1/xx unknown
- 2001-04-10 BR BR0111059-4A patent/BR0111059A/pt not_active Application Discontinuation
- 2001-04-10 US US10/296,761 patent/US20030199698A1/en not_active Abandoned
- 2001-04-10 AU AU2001260193A patent/AU2001260193A1/en not_active Abandoned
- 2001-04-10 WO PCT/EP2001/004112 patent/WO2001092214A1/de not_active Application Discontinuation
- 2001-04-10 SK SK1552-2002A patent/SK15522002A3/sk unknown
- 2001-04-10 CA CA002410628A patent/CA2410628A1/en not_active Abandoned
- 2001-04-10 EP EP01933812A patent/EP1289941A1/de not_active Withdrawn
- 2001-04-10 HU HU0301957A patent/HUP0301957A2/hu unknown
- 2001-04-10 MX MXPA02011801A patent/MXPA02011801A/es unknown
- 2001-04-10 JP JP2002500829A patent/JP2003535074A/ja active Pending
- 2001-05-30 AR ARP010102578A patent/AR029931A1/es unknown
-
2002
- 2002-11-29 NO NO20025740A patent/NO20025740D0/no not_active Application Discontinuation
- 2002-12-19 ZA ZA200210301A patent/ZA200210301B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR029931A1 (es) | 2003-07-23 |
WO2001092214A1 (de) | 2001-12-06 |
NO20025740L (no) | 2002-11-29 |
KR20030007752A (ko) | 2003-01-23 |
PL358688A1 (en) | 2004-08-09 |
DE10027024A1 (de) | 2001-12-06 |
ZA200210301B (en) | 2004-09-06 |
BR0111059A (pt) | 2003-04-15 |
NO20025740D0 (no) | 2002-11-29 |
EP1289941A1 (de) | 2003-03-12 |
US20030199698A1 (en) | 2003-10-23 |
CZ20023588A3 (cs) | 2003-02-12 |
HUP0301957A2 (hu) | 2003-11-28 |
AU2001260193A1 (en) | 2001-12-11 |
MXPA02011801A (es) | 2003-04-10 |
JP2003535074A (ja) | 2003-11-25 |
CA2410628A1 (en) | 2002-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK8292003A3 (en) | Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours | |
SK4472000A3 (en) | Benzamidine derivatives as factor xa inhibitors, process for their preparation, the use thereof and pharmaceutical composition containing the same | |
SK12152001A3 (sk) | Derivát pyrazol-3-ónu ako faktor Xa inhibítorov, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje | |
RU2301228C2 (ru) | ПРОИЗВОДНЫЕ ФЕНОКСИ-N-[4-(1,1-ДИОКСОИЗОТИАЗОЛИДИН-2-ИЛ)ФЕНИЛ]-ВАЛЕРАМИДА И ДРУГИЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА КОАГУЛЯЦИИ Ха ДЛЯ ЛЕЧЕНИЯ ТРОМБЭМБОЛИЧЕСКИХ БОЛЕЗНЕЙ И ОПУХОЛЕЙ | |
CZ20032935A3 (cs) | Derivát kyseliny šťavelové, způsob jeho přípravy, jeho použití a farmaceutický prostředek, který ho obsahuje | |
ES2377497T3 (es) | Derivados de fenilo como inhibidores de factor XA | |
JP4699985B2 (ja) | カルボキサミド誘導体及びその第Xa因子の阻害剤としての使用 | |
JP4567439B2 (ja) | カルボン酸アミド | |
SK1512003A3 (en) | N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives | |
JP2004523466A (ja) | 環状アミノ酸誘導体 | |
SK15522002A3 (sk) | Derivát esteru kyseliny karbaminovej ako inhibítor faktora Xa, spôsob jeho prípravy, jeho použitia a farmaceutický prostriedok, ktorý ho obsahuje | |
JP2003535075A (ja) | グリシンアミド | |
SK1972003A3 (en) | Acetamide derivatives and the use thereof as inhibitors of coagulation factors XA and VIIA | |
JP2004525119A (ja) | フェニル誘導体および血栓塞栓性疾患または腫瘍の処置におけるこれらの使用 | |
SK1992003A3 (en) | Urethane derivative, method for its preparation, its use and pharmaceutical composition comprising same | |
JP2005519114A (ja) | セミカルバジド誘導体および抗血栓剤としてのこれらの使用 | |
SK492004A3 (en) | Carbohydrate derivatives | |
CZ20001183A3 (cs) | Derivát benzamidinu jako inhibitor faktoru XA, způsob jeho přípravy, jeho použití a farmaceutický prostředek, který ho obsahuje |